drugset / Trial / NCT05558007
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine efficacy, safety and tolerabiltiy of topically applied BZ371A in patients that experienced RP, in combination with daily tadalafil compared to placebo.
Timeline
- Start
- 2023-11-22
- Primary completion
- 2024-12-31
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BZ371A | Unknown | 5 mg/ml | Topical |
| Comparator | Tadalafil | Small molecule | 5 mg | Oral |